Similar to NSCLC and other cancers, one study describes several CAF subtypes in human breast cancer, including ECM-myCAFs and TGF-β-myCAFs, albeit with somewhat different marker gene signatures compared to CAFs from the cancers described above (Kieffer et al. 2020). This evidence concerns the gene TGFB1 and breast carcinoma.